Greg B. Petersen's most recent trade in Pros Holdings Inc was a trade of 11,262 Restricted Stock Units done . Disclosure was reported to the exchange on May 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pros Holdings Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 11,262 | 11,262 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 08 May 2025 | 6,125 | 125,170 (0%) | 0% | 16.9 | 103,329 | Common Stock |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2025 | 6,125 | 0 | - | - | Restricted Stock Units | |
Plus Therapeutics Inc | Greg B. Petersen | Director | 18 Feb 2025 | 40,122 | 40,122 | - | - | Stock Option (Right to Buy) | ||
Plus Therapeutics Inc | Greg B. Petersen | Director | 11 Sep 2024 | 12,500 | 48,921 (1%) | 0% | 1.4 | 16,875 | Common Stock | |
Plus Therapeutics Inc | Greg B. Petersen | Director | 11 Sep 2024 | 3,650 | 3,650 | - | - | Stock Option (Right to Buy) | ||
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2024 | 7,205 | 0 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.63 per share. | 11 May 2024 | 7,205 | 119,045 (0%) | 0% | 30.6 | 220,689 | Common Stock |
Pros Holdings Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2024 | 6,125 | 6,125 | - | - | Restricted Stock Units | |
Plus Therapeutics Inc | Greg B. Petersen | Director | 08 May 2024 | 24,510 | 24,510 | - | - | Warrants (Right to buy) | ||
Plus Therapeutics Inc | Greg B. Petersen | Director | 08 May 2024 | 12,255 | 36,421 (0%) | 0% | 2.0 | 25,000 | Common Stock | |
Plus Therapeutics Inc | B. Petersen Greg | Director | 22 Feb 2024 | 2,250 | 2,250 | - | - | Stock Option (Right to Buy) | ||
Pros Holdings Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 7,205 | 7,205 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 6,809 | 0 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.98 per share. | 11 May 2023 | 6,809 | 114,223 (0%) | 0% | 25.0 | 170,089 | Common Stock |
Pros Holdings Inc | Greg B. Petersen | Director | Sale of securities on an exchange or to another person at price $ 24.61 per share. | 11 May 2023 | 2,383 | 111,840 (0%) | 0% | 24.6 | 58,646 | Common Stock |
Plus Therapeutics Inc | Greg B. Petersen | Director | 15 Feb 2023 | 20,182 | 20,182 | - | - | Stock Option (Right to Buy) | ||
Pros Holdings Inc | Greg B. Petersen | Director | Sale of securities on an exchange or to another person at price $ 25.76 per share. | 04 Nov 2022 | 6,000 | 107,414 (0%) | 0% | 25.8 | 154,560 | Common Stock |
Plus Therapeutics Inc | Greg B. Petersen | Director | 17 May 2022 | 30,000 | 62,500 (1%) | 0% | 0.6 | 16,500 | Common Stock | |
Pros Holdings Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 6,809 | 6,809 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.23 per share. | 12 May 2022 | 4,388 | 114,950 (0%) | 0% | 24.2 | 106,321 | Common Stock |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 4,388 | 0 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Sale of securities on an exchange or to another person at price $ 24.91 per share. | 12 May 2022 | 1,536 | 113,414 (0%) | 0% | 24.9 | 38,262 | Common Stock |
Plus Therapeutics Inc | Greg B. Petersen | Director | 27 Oct 2021 | 12,500 | 32,500 (0%) | 0% | 1.7 | 21,500 | Common Stock | |
Aterian Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 8,449 | 58,355 (0%) | 0% | 0 | Common Stock | |
Aterian Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 1,281 | 49,906 (0%) | 0% | 0 | Common Stock | |
Plus Therapeutics Inc | Greg B. Petersen | Director | 25 May 2021 | 6,336 | 6,336 | - | - | Stock Option (Right to Buy) | ||
Pros Holdings Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,388 | 4,388 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 4,811 | 0 | - | - | Restricted Stock Units | |
Pros Holdings Inc | Greg B. Petersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.37 per share. | 29 Apr 2021 | 4,811 | 112,246 (0%) | 0% | 44.4 | 213,464 | Common Stock |
Pros Holdings Inc | Greg B. Petersen | Director | Sale of securities on an exchange or to another person at price $ 43.72 per share. | 29 Apr 2021 | 1,684 | 110,562 (0%) | 0% | 43.7 | 73,624 | Common Stock |
Aterian Inc | Greg B. Petersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 3,300 | 48,625 (0%) | 0% | 0 | Common Stock | |
Plus Therapeutics Inc | Greg B. Petersen | Director | 13 Aug 2020 | 10,000 | 20,000 (0%) | 0% | 2.8 | 28,000 | Common Stock | |
Plus Therapeutics Inc | Greg B. Petersen | Director | 12 Aug 2020 | 10,000 | 10,000 (0%) | 0% | 2.5 | 25,200 | Common Stock | |
Aterian Inc | Greg B. Petersen | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 11 Jun 2020 | 2,000 | 45,325 (0%) | 0% | 5 | 10,000 | Common Stock |
Aterian Inc | Greg B. Petersen | Director | Purchase of securities on an exchange or from another person at price $ 5.65 per share. | 10 Jun 2020 | 5,000 | 43,325 (0%) | 0% | 5.7 | 28,250 | Common Stock |
Aterian Inc | Greg B. Petersen | Director | Purchase of securities on an exchange or from another person at price $ 5.47 per share. | 08 Jun 2020 | 5,000 | 38,325 (0%) | 0% | 5.5 | 27,350 | Common Stock |
Aterian Inc | Greg B. Petersen | Director | Purchase of securities on an exchange or from another person at price $ 5.35 per share. | 08 Jun 2020 | 5,000 | 33,325 (0%) | 0% | 5.4 | 26,750 | Common Stock |